http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17690765

Outgoing Links

Predicate Object
contentType Journal Article|Retraction of Publication
issn 0753-3322
pageRange 112854-
publicationName Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
startingPage 112854
bibliographicCitation Gao W, Ge S, Sun J. Retraction notice to \"Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion\" [Biomed. Pharmacother. 109 (2019) 1062-1069]. Biomed Pharmacother. 2022 Jun;150():112854. doi: 10.1016/j.biopha.2022.112854. PMID: 35341636.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15ca89b1cd4bb74a14ce626347786c0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b5d770129a586b4519f582f4224151f
date 202206
identifier https://doi.org/10.1016/j.biopha.2022.112854
https://pubmed.ncbi.nlm.nih.gov/35341636
isPartOf https://portal.issn.org/resource/ISSN/0753-3322
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1156
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Retraction notice to “Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion” [Biomed. Pharmacother. 109 (2019) 1062–1069]
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49798941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146160313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102004514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90477939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15558545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129316867
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Total number of triples: 27.